Connect your AI

ClearPoint Neuro CLPT Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

IAR

Integra LifeSciencesIART

——

Merit Medical SystemsMMSI

——

ITG

Integer HoldingsITGR

——

Ginkgo BioworksDNA

——

Other financials

Income statement

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total equity$18.8M-5.7%

Total assets$93.4M+211%

Cash flow

Operating cash flow-$8.0M-29.1%

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ClearPoint Neuro's accrued progress collections and price adjustments?: ClearPoint Neuro (CLPT) reported accrued progress collections and price adjustments of $608K in Q1 2026.
How has ClearPoint Neuro's accrued progress collections and price adjustments changed year-over-year?: ClearPoint Neuro's accrued progress collections and price adjustments increased by 70.3% year-over-year, from $357K to $608K.